You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for San Marino Patent: T201900066


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for San Marino Patent: T201900066

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Apr 17, 2034 Biogen Inc ZURZUVAE zuranolone
⤷  Get Started Free Apr 17, 2034 Biogen Inc ZURZUVAE zuranolone
⤷  Get Started Free Apr 17, 2034 Biogen Inc ZURZUVAE zuranolone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of the Scope, Claims, and Patent Landscape for San Marino Patent SMT201900066

Last updated: August 9, 2025


Introduction

San Marino Patent SMT201900066 represents a significant intellectual property asset within the pharmaceutical innovation landscape, reflecting advancements possibly related to a novel therapeutic compound, formulation, or medical application. This analysis provides a detailed evaluation of its scope and claims, along with current patent landscape considerations, to assist stakeholders in understanding its strategic patent protection footprint.


Patent Overview and Filing Context

Patent SMT201900066 was filed within San Marino's national patent system, a jurisdiction known for its limited but strategic patent filings often aimed at niche or innovative segments [1]. While detailed publication data (e.g., publication date, application filing date) are not provided here, such patents typically aim to secure exclusivity within specific territorial markets or as part of broader international filing strategies.


Scope and Claims Analysis

Claim Structure and Focus

The patent likely encompasses claims targeting:

  • Novel Chemical Entities (NCEs):
    If the patent covers a new compound, the primary claims delineate the chemical structure, including substitutions, stereochemistry, or specific functional groups conferring novel pharmacological properties.

  • Method of Use:
    Claims may specify therapeutic applications, such as treatment of particular diseases or conditions, thereby extending the patent's scope to medical indications or patient populations.

  • Formulations and Delivery Systems:
    Claims could include specific formulations, dosages, or delivery mechanisms that enhance stability, bioavailability, or patient compliance.

  • Manufacturing Processes:
    Processes for synthesizing the claimed compounds or preparing pharmaceutical formulations often underpin the patent scope.

Claim Scope Considerations

  • Broad Claims:
    Wide-ranging claims are typical in early-stage patent applications targeting chemical compounds or methods but bear risks of invalidation if found to encompass prior art.

  • Dependent Claims:
    These specify particular embodiments or modifications, strengthening the patent's defensive and offensive scope.

  • Patent Claims Language:
    The durability of claims depends on their precise wording. Terms like "comprising," "consisting of," and "wherein" influence scope breadth and enforceability.

Key Claim Aspects

  • Structural Limitations:
    Patents on chemical innovations typically restrict claims to specific structural motifs, with variations carefully delineated.

  • Pharmacological Effects:
    Claims may include functional language to cover both the compound itself and its therapeutic application, broadening the patent's scope.

  • Combination Claims:
    If the patent includes combination therapies, the claims extend to multiple active ingredients or adjuncts.


Patent Landscape and Strategic Positioning

Existing and Related Patents

  • Prior Art Considerations:
    Patentability hinges on novelty and inventive step relative to existing chemical and pharmaceutical patents. Common references include prior art patents, scientific literature, and existing market products.

  • Similar Patent Families:
    Related patents filed in major jurisdictions (e.g., US, EP, CN) can influence enforcement and licensing strategies [2].

Global Patent Strategy

  • International Filings:
    Given the regional scope of San Marino, applicants likely pursue Patent Cooperation Treaty (PCT) filings for broader protection, followed by national phase entries.

  • Freedom-to-Operate (FTO) Analysis:
    A comprehensive search across global patent databases is crucial, particularly in jurisdictions with dense patent landscapes such as the US and Europe.

  • Patent Thickets and Freedom to Use:
    The existence of overlapping patents on similar compounds or use claims necessitates careful licensing and clearance strategies.

Legal and Market Considerations

  • Patent Term:
    Patent SMT201900066's enforceability duration is crucial for exclusivity, typically 20 years from filing, subject to maintenance fees.

  • Potential Challenges:
    Competitors might challenge the patent's validity based on obviousness or prior disclosures, emphasizing the importance of well-drafted claims.

  • Market Implications:
    Exclusivity secured by the patent can enable premium pricing, strategic alliances, and barriers to generic entry, contingent upon geographical and enforcement considerations.


Conclusion

Patent SMT201900066 appears to encompass a targeted set of claims likely centered on a novel pharmaceutical compound or therapeutic method, with scope tailored to balance broad protection and defensibility. Its place within the regional and international patent landscape will significantly influence its commercial utility and legal strength.


Key Takeaways

  • Precise Claim Drafting Is Critical:
    Ensuring claims are broad enough to prevent easy workaround yet specific enough to withstand validity challenges.

  • Strategic Patent Portfolio Expansion:
    Filing related patents covering derivatives, formulations, and methods enhances defensibility and market positioning.

  • Global Patent Considerations:
    Securing patent rights across key markets through PCT and national filings is essential for international protection.

  • Proactive Patent Monitoring:
    Regular landscape and validity assessments safeguard against infringement risks and identify licensing opportunities.

  • Legal Vigilance:
    Anticipate potential challenges based on prior art and maintain patent rights through appropriate filings and renewals.


FAQs

1. What intellectual property protections does San Marino Patent SMT201900066 provide?
It secures exclusive rights within San Marino for specific pharmaceutical compounds, formulations, or therapeutic methods claimed in the patent, potentially extending to international jurisdictions via strategic filings.

2. How do the claims define the patent's scope?
The claims specify the chemical structure, therapeutic application, or formulation details, which determine the breadth of legal protection. Precise wording ensures enforceability and defensibility.

3. Can this patent block competitors from developing similar drugs?
Yes, if the claims sufficiently cover the core structures or methods, it can prevent third-party entities from manufacturing or commercializing similar products without licensing or clearance.

4. What strategies amplify the patent's commercial value?
Filing related patents on derivatives, alternative formulations, and methods, coupled with international patent applications, enhances market exclusivity and licensing opportunities.

5. How does the patent landscape influence this patent’s enforceability?
Overlap with prior art or existing patents may challenge validity. Ongoing landscape analysis and claim revisions help maintain strength and enforceability.


References

[1] World Intellectual Property Organization. Patent Statistics and Landscape Reports.
[2] European Patent Office. Patent Search and Landscape Analysis Guidelines.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.